Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NDUFA4L2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SHMT2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
STAC3 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
GEO DataSets Gene Chromosome neighbors Homologene neighbors
NXPH4 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
LRP1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
R3HDM2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
STAT6 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
NAB2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
NEMP1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
MYO1A - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
INHBC - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
INHBE - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
TAC3 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
GLI1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
ZBTB39 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
HBCBP - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
GEO DataSets Gene Profile neighbors Chromosome neighbors
ARHGAP9 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
MARS - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
DDIT3 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on